Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation
Authors:
- 13 February 2009
- journal article
- case report
- Published by Wiley in Transfusion
- Vol. 49 (3) , 555-562
Abstract
BACKGROUND: A case of donor cell leukemia (DCL) is reported. A 42‐year‐old female developed acute myeloid leukemia (AML) of donor cell origin 18 months after a bone marrow transplant (BMT) from her brother. At the time DCL presented, the donor‐brother was also diagnosed with AML showing identical cytogenetic abnormalities. The classification of DCL and recommendations for laboratory testing of potential hematopoietic stem cell (HSC) donors are discussed.STUDY DESIGN AND METHODS: Marrow specimens were obtained from the posterior iliac crest and analyzed using standard techniques. Leukemic cells were analyzed by flow cytometry. Karyotyping and fluorescence in situ hybridization were performed using standard methods.RESULTS: The recipient‐sister's original diagnosis was erythroleukemia. Chromosome analysis showed a 46,XX,t(3;5)(q25;q34) karyotype. Both the recipient's new AML and the donor's AML showed an identical karyotype: 46,XY,inv(3)(q21q26),‐7. Both patients were resistant to therapy and died.CONCLUSION: The clinical and biological aspects of DCL are discussed including the distinction between transformation of healthy donor cells to leukemic cells and transmission of preformed leukemic cells. The former represents almost all the reported cases of DCL compared with transmission of leukemic cells from donor to recipient. With an aging donor population, it is estimated that the latter will increase. Increased testing of older donors to include routine morphologic study of blood and marrow, cytogenetic studies, and evaluation for clonal lymphoproliferative disorders is recommended.Keywords
This publication has 20 references indexed in Scilit:
- Donor cell leukemia: A critical reviewLeukemia & Lymphoma, 2007
- Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- Transmission of donor illness by stem cell transplantation: should screening be different in older donors?Bone Marrow Transplantation, 2004
- Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individualsBone Marrow Transplantation, 2004
- Transmission of Chronic Myeloid Leukemia through Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2003
- Transmission of a T-Cell Lymphoma by Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 2001
- Donor cell leukemia: Report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literatureAmerican Journal of Hematology, 2000
- Haemopoietic reconstitution by donor‐derived myelodysplastic progenitor cells after haemopoietic stem cell transplantationBritish Journal of Haematology, 1999
- A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 1994
- Inadvertent Transmission of a Donor's Acute Myeloid Leukemia in Bone Marrow Transplantation for Chronic Myelocytic LeukemiaNew England Journal of Medicine, 1990